Printer Friendly

CORDIS PREDATOR LONG BALLOON CATHETERS APPROVED FOR U.S. MARKET RELEASE

 MIAMI, Aug. 24 /PRNewswire/ -- Cordis Corporation (NASDAQ-NMS: CORD) said today that the Food and Drug Administration (FDA) has approved the U.S. market release of Predator PTCA Dilatation Catheters with 3 cm and 4 cm balloons (long balloons). Dilatation, or balloon, catheters are used to open coronary arteries occluded by the buildup of fatty deposits, or plaque, associated with atherosclerosis.
 Today's announcement follows by less than a month the agency's release of standard Predator catheters, which feature 2 cm balloons. Long-balloon catheters address the needs of an expanding segment of the market in which clinical indications require the use of a balloon longer than the standard size. Both Predator and Predator long balloon devices are compatible with up to an .014" guidewire and thus compete in the largest segment of the U.S. angioplasty market.
 Robert C. Strauss, president and chief executive officer, called the approval "an affirmation of the company's increasingly productive development and regulatory efforts. With 10 new angioplasty catheters approved by FDA in the past 13 months, Cordis' product portfolio is among the broadest and most advanced in the world."
 Miami-based Cordis Corporation manufactures and markets a variety of medical devices and systems for the angiographic and neuroscience markets.
 -0- 8/24/93
 /CONTACT: Chick McDowell, vice president, corporate relations and assistant secretary of Cordis Corporation, 305-824-2821/
 (CORD)


CO: Cordis Corporation ST: Florida IN: MTC SU:

AW-RC -- FL004 -- 5334 08/24/93 09:09 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 24, 1993
Words:238
Previous Article:TROPICANA SELECTS NEW HEALTH AND DENTAL CARE CARRIERS
Next Article:HYDRON TECHNOLOGIES AND QVC NETWORK REACH AGREEMENT IN PRINCIPLE TO MARKET PROPRIETARY PRODUCTS TO CONSUMERS
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters